SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-062594
Filing Date
2020-05-15
Accepted
2020-05-15 16:07:14
Documents
1
Period of Report
2020-05-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2019970-1_4.html 4  
1 OWNERSHIP DOCUMENT tm2019970-1_4.xml 4 5111
  Complete submission text file 0001104659-20-062594.txt   6639
Mailing Address C/O DUSA PHARMACEUTICALS INC 25 UPTON DR WILMINGTON MA 01887
Business Address
CHAKOUTIS PETER M (Reporting) CIK: 0001257798 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35853 | Film No.: 20885077

Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Issuer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus